CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in miceJulia Weber, Roland Rad, Rupert Öllinger et al.|Proceedings of the National Academy of Sciences|2015Cited by 195
A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancerRoland Rad, Allan Bradley, Lena Rad et al.|Nature Genetics|2014Cited by 81
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Gabriele Luppi, Jean‐Frédéric Blanc et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 61
Community-driven development of a modified progression-free survival ratio for precision oncologyAndreas Möck, Anna Lena Illert, Christoph E. Heilig et al.|ESMO Open|2019Cited by 44
Atezolizumab and Bevacizumab with Transarterial Chemoembolization in Hepatocellular Carcinoma: The DEMAND Trial ProtocolNajib Ben Khaled, Enrico N. De Toni, Max Seidensticker et al.|Future Oncology|2022Cited by 35